84 results match your criteria: "Kahn Sagol Maccabi Research & Innovation Center[Affiliation]"

Identifying which patients should undergo serologic screening for celiac disease (CD) may help diagnose patients who otherwise often experience diagnostic delays or remain undiagnosed. Using anonymized outpatient data from the electronic medical records of Maccabi Healthcare Services, we developed and evaluated five machine learning models to classify patients as at-risk for CD autoimmunity prior to first documented diagnosis or positive serum tissue transglutaminase (tTG-IgA). A train set of highly seropositive (tTG-IgA > 10X ULN) cases (n = 677) with likely CD and controls (n = 176,293) with no evidence of CD autoimmunity was used for model development.

View Article and Find Full Text PDF
Article Synopsis
  • Eosinophilic gastrointestinal disorders (EGIDs) are rising significantly in incidence and prevalence, with a major focus on eosinophilic esophagitis (EoE), particularly in Israel from 2014 to 2021.
  • The study, based on electronic medical records of a population of 2.4 million, shows that the incidence rate of EGIDs tripled during the study period, while prevalence soared from 14.53 to 51.43 per 100,000 persons.
  • The trends for increased cases are consistent across different age groups and sexes, indicating that the rise in EGIDs, especially EoE, shows no signs of plateauing by the end of 2021.
View Article and Find Full Text PDF
Article Synopsis
  • Alopecia areata (AA) and celiac disease are both immune-related conditions, and this study investigates their potential connection in a large population.
  • The research analyzed data from over 33,000 AA patients and 66,000 healthy controls, finding that celiac disease prevalence was notably higher in those with AA (1.1% vs 0.6%).
  • The increased risk for celiac disease was especially significant in AA patients over 40 years old, suggesting a need for early diagnosis and prevention strategies.
View Article and Find Full Text PDF

Study Question: What are the roles of maternal preconception diabetes and related periconceptional hyperglycemia on the risk of major congenital malformations (MCMs) in offspring?

Summary Answer: Maternal periconceptional glycated hemoglobin (HbA1c) levels over 5.6% were associated with an increased risk of congenital heart defects (CHD) in the offspring, and maternal preconception diabetes was associated with an increased risk of CHD, including when HbA1c levels were within euglycemic ranges.

What Is Known Already: Maternal preconception diabetes has been linked with MCMs in the offspring.

View Article and Find Full Text PDF

Purpose: To assess the validity of privacy-preserving synthetic data by comparing results from synthetic versus original EHR data analysis.

Methods: A published retrospective cohort study on real-world effectiveness of COVID-19 vaccines by Maccabi Healthcare Services in Israel was replicated using synthetic data generated from the same source, and the results were compared between synthetic versus original datasets. The endpoints included COVID-19 infection, symptomatic COVID-19 infection and hospitalization due to infection and were also assessed in several demographic and clinical subgroups.

View Article and Find Full Text PDF

Introduction: Proton pump inhibitors (PPIs) are one of the most widely used drugs worldwide [Gut Liver. 2017;11(1):27-37]. The use of PPI has become a common practice and is overprescribed for all patients with cancer including patients with hematological malignancies.

View Article and Find Full Text PDF

Objective: To assess treatment patterns and the association between long-term glucocorticoid (GC) and hydroxychloroquine (HCQ) use and damage accrual in patients with systemic lupus erythematosus (SLE).

Methods: A retrospective study including patients with SLE using the computerised database of a large health maintenance organisation. Patients were matched with subjects from the general population.

View Article and Find Full Text PDF

Clinical significance of FLC tests in patients without other evidence of hematologic disorder.

Clin Exp Med

August 2024

Tel -Aviv Sourasky (Ichilov) Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Article Synopsis
  • - The study examined the clinical relevance of abnormal free light chain (FLC) test results in patients who show non-specific symptoms but have no known plasma cell dyscrasia (PCD) or lymphoproliferative disease (LPD), analyzing data from 8,661 patients tested between 2007-2023.
  • - Researchers categorized FLC ratios into normal, slightly abnormal, moderately abnormal, and significantly abnormal, finding that a significant portion of patients with abnormal results were later diagnosed with PCD or LPD within a median follow-up of 52 months.
  • - The findings indicated that abnormal FLC ratios are strong indicators for diagnosing PCD/LPD, highlighting the importance of these tests for early detection, even when
View Article and Find Full Text PDF

Peripheral Blood Eosinophilia at Diagnosis of Inflammatory Bowel Disease Is Associated with Severe Disease Course; A Nationwide Study From the epi-IIRN Cohort.

J Crohns Colitis

August 2024

Pediatric Gastroenterology Institute, "Dana-Dwek" Children's Hospital, Tel Aviv Sourasky Medical Center and the Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Article Synopsis
  • A nationwide study assessed the link between high eosinophil counts (PBE) and long-term outcomes in patients with inflammatory bowel diseases (IBD).
  • The analysis included over 28,000 patients, revealing that PBE occurred more frequently in individuals with ulcerative colitis and in pediatric patients compared to adults.
  • Results indicated that PBE is a significant predictor of severe disease progression, increased hospitalization, and higher medication needs in IBD patients, highlighting its potential as a marker for adverse outcomes and target for therapies.
View Article and Find Full Text PDF

The Prevalence and Characteristics of Inflammatory Bowel Disease-related Ocular Involvement in Children.

Inflamm Bowel Dis

July 2024

The Juliet Keidan IInstitute of Pediatric Gastroenterology and Nutrition, Shaare Zedek Medical Center, The Hebrew University, Jerusalem, Israel.

Background: Ocular manifestations (OMs) in patients with inflammatory bowel disease (IBD) are uncommon, particularly in children. We aimed to explore the prevalence and characteristics of IBD-associated OM in a large cohort study.

Methods: A cross-sectional study was performed using the Maccabi Healthcare Services (MHS) database.

View Article and Find Full Text PDF

The integration of genetic information (GI) into the electronic health record (EHR) seems inevitable as the mainstreaming of genomics continues. Such newly provided accessibility to GI could be beneficial for improving health care, as well as for supporting clinical decision-making and health management. Notwithstanding these promising benefits, the automatic integration of GI into the EHR, allowing unrestricted access to one's GI through patient portals, carries various knowledge-related risks for patients.

View Article and Find Full Text PDF

Background: Metformin is the most used oral antidiabetic medication. Despite its established safety profile, it has known antiandrogenic and epigenetic modifying effects. This raised concerns about possible adverse developmental effects caused by genomic alterations related to paternal use of metformin during the spermatogenesis period preceding conception.

View Article and Find Full Text PDF

Introduction: Vitiligo, a chronic autoimmune skin depigmentation disease with an unpredictable course, has been associated with several comorbid autoimmune and psychological conditions. Our current understanding of vitiligo burden and management in the real world is limited. This real-world analysis presents data on vitiligo epidemiology, comorbidities, and treatment of patients in Israel.

View Article and Find Full Text PDF

Background: Limited knowledge exists regarding behavioral and biomarker shifts during the period from respiratory infection exposure to testing decisions (the diagnostic decision period), a key phase affecting transmission dynamics and public health strategy development. This study aims to examine the changes in behavior and biomarkers during the diagnostic decision period for COVID-19, influenza, and group A streptococcus (GAS).

Methods: We analyzed data from a two-year prospective cohort study involving 4795 participants in Israel, incorporating smartwatch data, self-reported symptoms, and medical records.

View Article and Find Full Text PDF

Low levels of vitamin D are associated with a shorter time to first treatment (TTFT) and inferior overall survival in patients with chronic lymphocytic leukemia (CLL). But whether vitamin D supplement affects the clinical course of patients with CLL, remains an open question. In this study, we aimed to retrospectively explore the clinical benefit of vitamin D supplement or one of its analogs, on TTFT and treatment-free survival (TFS) in a large cohort of patients with asymptomatic CLL, who were under watch-and-wait approach.

View Article and Find Full Text PDF

Background/aim: The treatment for chronic lymphocytic leukemia (CLL) has changed dramatically over the last two decades. The current study aimed to investigate the impact on overall survival (OS) and time to next treatment (TTT) among CLL patients from 1998 to 2022.

Patients And Methods: The cohort was based on data obtained from electronic medical records of Maccabi, the second largest healthcare organization in Israel.

View Article and Find Full Text PDF

Durability of the First Biologic in Children and Adults With Ulcerative Colitis: A Nationwide Study from the epi-IIRN.

Inflamm Bowel Dis

April 2024

Juliet Keidan Institute of Pediatric Gastroenterology Hepatology and Nutrition, Shaare Zedek Medical Center, The Hebrew University of Jerusalem, Jerusalem, Israel.

Article Synopsis
  • This nationwide study analyzed the durability of first-line biologics in ulcerative colitis (UC) patients, focusing on monotherapy versus combotherapy with immunomodulators over a median follow-up of 7 years.
  • The results showed that the durability rates for pediatric and adult patients were similar, with 43% of patients maintaining their initial biologic treatment after 5 years.
  • Additionally, anti-TNF biologics demonstrated comparable durability to vedolizumab, but were more effective when used in combination with other therapies.
View Article and Find Full Text PDF
Article Synopsis
  • - The study investigated how the COVID-19 pandemic impacted the incidence of inflammatory bowel diseases (IBD) in Israel and Sweden, two countries with different lockdown strategies.
  • - Findings revealed that IBD incidence in Israel significantly decreased during the pandemic, while Sweden experienced a slight decrease initially followed by an increase, particularly among elderly-onset patients.
  • - The research concluded that stricter lockdowns in Israel correlated with a greater reduction in IBD cases compared to Sweden, prompting a need for further research on the long-term effects of the pandemic on IBD.
View Article and Find Full Text PDF
Article Synopsis
  • A nationwide study in Israel examined how early use of biologic treatments affects outcomes in patients with Crohn's disease (CD) and ulcerative colitis (UC) from 2005 to 2020.
  • Among 34,375 patients, earlier initiation of biologics showed a small reduction in surgery rates and steroid dependency for CD, but no significant improvements were seen for UC or in the pediatric group.
  • The findings suggest that while early biologic treatment can lead to some benefits for CD patients, overall results for UC and in the pediatric population are less promising, indicating more research is needed.
View Article and Find Full Text PDF

Durability of Adalimumab and Infliximab in Children With Crohn's Disease: A Nationwide Comparison From the epi-IIRN Cohort.

Inflamm Bowel Dis

November 2024

Juliet Keidan Institute of Pediatric Gastroenterology Hepatology and Nutrition, Shaare Zedek Medical Center, The Hebrew University of Jerusalem, Israel.

Article Synopsis
  • The study examined the effectiveness of infliximab and adalimumab as first biologic treatments in children with Crohn's disease, using a nationwide cohort from Israel.
  • Results showed that adalimumab monotherapy had significantly better long-term durability compared to infliximab monotherapy, while the two treatments had similar durability when used in combination.
  • Overall, the findings suggest that adalimumab should be considered as the preferred first-line biologic therapy for pediatric Crohn's disease patients.
View Article and Find Full Text PDF

The current study examined longitudinal associations between early screen media exposure (assessed at 6, 12, and 24 months) and the child's motor and language/communication development at the ages of 24 and 36 months. We also aimed to study whether these associations varied by socioeconomic status (SES). Participants were 179 parent-infant dyads, recruited from well-baby clinic services during routine visits.

View Article and Find Full Text PDF

Human parvovirus B19 (B19V) has a wide clinical spectrum, ranging from an asymptomatic infection to a life threatening one. During pregnancy, it can lead to fetal loss and hydrops fetalis. This retrospective study examined the incidence rates of B19V in Israel, analyzing anonymized electronic medical records of 2.

View Article and Find Full Text PDF
Article Synopsis
  • * Young adults and those of middle socioeconomic status showed the highest incidence rates, with males being more affected than females (0.72 incidence rate ratio).
  • * The research found stable yearly incidence rates for the entire cohort, but a significant increase in incidence among males aged 18 to 30, raising concerns about associated risk factors such as stress.
View Article and Find Full Text PDF

Background: Whole exome sequencing (WES) furthered our understanding of various tumors. We assessed the occurrence of germline likely pathogenic/pathogenic (LP/P) variants, disease features, and clinical outcomes in early-onset prostate cancer.

Methods: This retrospective study (N = 134) included consecutive prostate cancer patients who donated blood samples for research purposes to the Kahn-Sagol-Maccabi biobank.

View Article and Find Full Text PDF